Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Dermatologic 1

Conditions

Neoplasms 1522Carcinoma, Non-Small-Cell Lung 758Breast Neoplasms 572Neoplasm Metastasis 531Colorectal Neoplasms 448Melanoma 390Leukemia, Myeloid, Acute 371Multiple Myeloma 364Ovarian Neoplasms 354Recurrence 336Lymphoma 334Advanced Solid Tumors 326Lymphoma, Non-Hodgkin 315Prostatic Neoplasms 302Pancreatic Neoplasms 285Advanced Solid Tumor 240Stomach Neoplasms 234Carcinoma, Renal Cell 226Squamous Cell Carcinoma of Head and Neck 211Lung Neoplasms 211Solid Tumor 204Leukemia, Lymphocytic, Chronic, B-Cell 198Triple Negative Breast Neoplasms 185Solid Tumors 183Carcinoma, Hepatocellular 165Hematologic Neoplasms 155Head and Neck Neoplasms 153Lymphoma, Large B-Cell, Diffuse 148Lymphoma, Follicular 146Glioblastoma 145

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × INDUSTRY × Advanced Melanoma × Clear all
NCT07107178 2025-08-06

A Clinical Study of BT02 for the Treatment of Patients With Advanced Malignant Melanoma

Biotroy Therapeutics

Phase 1 Not yet recruiting
58 enrolled
DermatologicOther solid neoplasm

Advanced Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡